This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

Proton pump inhibitor. This product is a fat-soluble weak alkaline drug that is easily concentrated in an acidic environment. Therefore, after oral administration, it can be specifically distributed in the secretory tubules of the gastric mucosal parietal cells and converted into the active form of sulfenamide in this high-acid environment. Then, it irreversibly combines with the sulfhydryl group of the H,K-ATPase (also known as the proton pump) in the secretory membrane of the parietal cells through a disulfide bond to form a complex of sulfenamide and the proton pump, thereby inhibiting the activity of the enzyme and blocking the final step of gastric acid secretion. Therefore, this product has a strong and lasting inhibitory effect on gastric acid secretion caused by various reasons.

Improve blood glucose tolerance in patients with type 2 diabetes, lower basal and postprandial blood glucose; reduce liver glycogen production, reduce intestinal absorption of sugar, increase peripheral sugar uptake and utilization to improve insulin sensitivity; will not cause hypoglycemia in patients with type 2 diabetes or patients with normal blood sugar (except in special circumstances); after treatment, insulin secretion remains unchanged, while fasting insulin levels and daily plasma insulin levels are reduced.

Extract from the above information

This product has a broad-spectrum antibacterial effect and strong antibacterial activity, and has strong antibacterial activity against most Enterobacteriaceae. It also has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Mycoplasma pneumoniae, and Chlamydia pneumoniae, but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.